⌘K

Login Start Free

Home/Filings/4/0001079973-25-001813

4//SEC Filing

Pacala Mark L 4

Accession 0001079973-25-001813

CIK 0001799191other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:55 PM ET

Size

8.0 KB

Accession

0001079973-25-001813

Insider Transaction Report

Form 4

Period: 2025-11-18

Oncology Institute, Inc.TOI

Director

Transactions

Sale
Common Stock
2025-11-18$4.00/sh−2,160$8,640→ 222,811 total
Sale
Common Stock
2025-11-18$4.00/sh−46,630$186,520→ 174,971 total
Sale
Common Stock
2025-11-18$4.00/sh−1,210$4,840→ 221,601 total

Footnotes (1)

[F1]Represents sale of Common Stock acquired from previously vested RSU awards.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1

filerCIK 0001321250

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:55 PM ET
Size: 8.0 KB

View on SEC.gov